Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05906147

Health ImprOvement Program of Bone in China

Status
Recruiting
Phase
Study type
Observational
Enrollment
5,000 (estimated)
Sponsor
Second Xiangya Hospital of Central South University · Academic / Other
Sex
All
Age
40 Years – 100 Years
Healthy volunteers

Summary

Fracture risk factors have long been identified as key factors in osteoporosis and fragility fractures. The WHO recommended Fracture risk assessmenttool (FRAX) applies clinical risk factors to assess the absolute risk of osteoporotic fractures in each individual. Our preliminary study suggests that FRAX estimates may underestimate the risk of fractures in the Chinese population. In order to optimize the risk prediction model of osteoporotic fractures, a treatment threshold and its optimal cutting point were initially established based on the data of the health management Center of the Second Xiangya Hospital of Central South University.

Conditions

Interventions

TypeNameDescription
OTHERRegular follow-upFollow-up of the population was conducted to track the incidence of fractures

Timeline

Start date
2021-02-27
Primary completion
2021-02-27
Completion
2031-02-27
First posted
2023-06-15
Last updated
2023-06-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05906147. Inclusion in this directory is not an endorsement.

Health ImprOvement Program of Bone in China (NCT05906147) · Clinical Trials Directory